Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT06029166
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06029166
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT06029166. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-10-01 (anticipated); primary completion 2026-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors
- Acronym
- IRAF-ISCM
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
- Lead sponsor
- University Hospital, Caen
- Collaborator
- University Hospital, Marseille
- Collaborator
- Groupe Hospitalier Pitie-Salpetriere
- Collaborator
- European Georges Pompidou Hospital
- Collaborator
- Hôpital Necker-Enfants Malades
- Collaborator
- Saint Antoine University Hospital
- Collaborator
- Hospices Civils de Lyon
- Collaborator
- Centre Hospitalier Universitaire de Saint Etienne
- Collaborator
- Biotronik SE & Co. KG
Record details
- Record id
cardio:ct-nct06029166- Content hash
9b5fd59c43921249aa0ce403ead6db94567960ca1269b27e89b0f7b6502ce71a